Fontel

Quick links to important sections

Fontel

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fontel

The medicine Fontel is a multicomponent pharmacological complex designed for oral consumption, integrating a phytopharmaceutical extract with essential vitamins to provide complementary support for liver health and metabolic processes.

Property Description
Active ingredient Silymarin (from Cao Carduus Marianus), Vit B complex, Vit Pp
Form Solid Oral Dosage Form (e.g., tablet, capsule)
Pharmacological class Hepatoprotective agent and Metabolic vitamin supplement
Common purpose Integrated support for liver function and overall energy metabolism
Origin Derived Combination (Natural plant extract + Synthetic/Isolated vitamins)

What Type of Drug is Fontel and How is it Classified?

Fontel is explicitly classified as a combined preparation, functioning under the high-level pharmacological categories of both a Hepatoprotective agent and a Metabolic vitamin supplement. As an oral dosage form, the preparation is intended for internal use. The basis for its hepatoprotective classification stems from the Cao Carduus Marianus component; the key active ingredient, Silymarin, is clinically recognized for its association with stabilizing liver cell membranes and reducing oxidative stress.


Fontel's Composition: Derived Combination of Phytopharmaceutical and Vitamins

The active composition of Fontel is a derived combination, utilizing the phytopharmaceutical derivative Cao Carduus Marianus (Milk Thistle extract) alongside the essential water-soluble vitamins Vit B (B-complex) and Vit Pp (Nicotinamide or Niacin). The B-group vitamins are incorporated for their role as vital coenzymes in numerous biochemical reactions critical for energy release and healthy neurological function. The inclusion of the full B-complex alongside the Silymarin compound addresses a broader patient profile, targeting individuals who require combined hepatic and metabolic support.


General Purpose: Integrated Support for Liver and Metabolism

The general purpose of Fontel is to provide integrated support by addressing two essential physiological needs simultaneously. The Cao Carduus Marianus component assists in cellular protection against environmental stressors. Concurrently, the Vit B and Vit Pp components contribute to metabolic enhancement by facilitating the conversion of nutrients into energy. This combined effect offers a supportive approach for maintaining general physiological vitality, often used in scenarios requiring broad, non-specific support for liver and metabolic well-being.

Regulatory References

  1. MedlinePlus B Vitamins

What side effects are possible with Fontel?

Possible side effects and safety information

This section outlines the adverse reactions and safety constraints for Fontel, based strictly on official regulatory documentation for its active ingredients (Silymarin, Vit B complex, and Nicotinamide).

Documented Adverse Reactions and Frequency

Adverse effects are categorized by the body system affected and the official frequency classification from regulatory documents.

System-Organ Class Specific Reactions (Examples) Official Frequency
Gastrointestinal Disorders Dry mouth, stomach-ache, diarrhoea, nausea, vomiting Uncommon
Skin & Subcutaneous Tissue Pruritus (itching), rash Uncommon
Immune System Disorders Urticaria, severe hypersensitivity reactions Frequency Not Known
Vascular Disorders Flushing (skin redness, feeling of warmth) Frequency Not Specified
Nervous System Disorders Headache Frequency Not Specified

The most serious adverse reaction documented in the labeling for the active components is Anaphylactic shock, which is categorized as Frequency Not Known.

Safety Constraints and Special Populations

Official regulatory information includes specific limitations and constraints for use:

  • Contraindications: Fontel is contraindicated for individuals with known hypersensitivity to any of its components or to plants belonging to the Asteraceae (Compositae) family.
  • Pregnancy and Breastfeeding: Use is not recommended during pregnancy or breastfeeding due to a lack of sufficient supporting safety data.
  • Special Caution: Precautionary notes exist for patients with active peptic ulcer disease.

Exposure-Related Safety Notes

The regulatory data for the Nicotinamide component notes that the severity of flushing may be less severe with certain sustained-release formulations compared to immediate-release forms.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation on Fontel overdose focuses on the risks associated with excessive intake of the vitamin components, particularly high doses of Pyridoxine (Vit B6) and Nicotinamide (Vit Pp).

Documented Overdose Manifestations

Classification Manifestation as Stated in Official Sources
Neurological Severe sensory neuropathy, ataxia, and coordination disturbance.
Systemic Hepatotoxicity (liver injury), significant hypotension, and severe cutaneous flushing.
Gastrointestinal Protracted nausea, vomiting, and general gastrointestinal upset.

Required Emergency Actions

The regulatory profile mandates immediate action when an overdose is suspected, due to the potential for serious outcomes.

  • Seek immediate medical attention upon confirmed or suspected overdose.
  • Contact emergency services immediately if symptoms include signs of hepatotoxicity, significant hypotension, or serious neurological events.
  • Management is defined as symptomatic and supportive treatment, as no specific antidote is known for this combination.
  • Hospital monitoring and laboratory monitoring, including liver enzymes, are required for observation and systemic support.

Therapeutic Uses of Fontel

What Fontel Treats: Main Uses and Benefits

Fontel plays a role in supporting integrated care across chronic liver health and systemic metabolic demands. It is generally used when patients experience symptoms linked to organ-specific functional stress and associated systemic imbalance. Preparations containing the extract's core component are traditionally used to support liver function and relieve digestive disorders.

The medication is relevant for managing conditions involving increased physiological stress on the liver, including non-alcoholic fatty liver disease (NAFLD) and other chronic pathologies, as well as addressing symptom clusters like general fatigue and mild digestive discomfort. It is commonly applied as a supportive measure in scenarios where the liver requires support against ongoing stressors and toxins, which may be evidenced by internal markers like elevated liver enzyme levels.

“The primary benefit supports the liver's response to ongoing stress, which contributes to easing the symptom load and supports general well-being during symptomatic phases.”

The benefit focuses on assisting with comfort and supporting systemic energy pathways during demanding periods.


Quick Fact: Support for Symptoms Related to Non-Specific Fatigue

Regulatory References

  1. European Medicines Agency (EMA) overview

Eligibility and Restrictions for Use

Fontel is a prescription medicine that can be used only in patients 2 years of age and older.

Contraindications and Restrictions

Official regulatory documents strictly prohibit the use of Fontel in patients who meet the following criteria:

  • Hypersensitivity: Patients with known allergy or hypersensitivity to fenfluramine (the active ingredient in Fontel) or any of its inactive components.
  • MAOI Use: Patients who are currently taking a Monoamine Oxidase Inhibitor (MAOI) or who have taken an MAOI within the last 14 days, due to the risk of a serious condition called serotonin syndrome.

Special Considerations

Use of this medicine is not recommended in patients with pre-existing hepatic impairment (liver disease) or moderate-to-severe renal impairment (kidney disease). The drug's distribution is managed through a Risk Evaluation and Mitigation Strategy (REMS) program, which requires specific monitoring due to the risk of serious heart and lung problems, including valvular heart disease and pulmonary arterial hypertension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fontel, which typically contains the active ingredient telmisartan, may be prescribed alone or in combination with other agents, such as diuretics or beta-blockers. Given its mechanism of action as an angiotensin II receptor blocker (ARB), it can interact with several classes of medicinal products, potentially requiring careful monitoring or dosage adjustment by a healthcare professional.

Interacting Product Category Potential Effect of Interaction
Potassium-Sparing Diuretics/Potassium Supplements Increased risk of hyperkalemia (high potassium levels). Co-administration is generally discouraged or requires close monitoring of blood potassium.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) May reduce the blood pressure-lowering effect of Fontel and increase the risk of worsening kidney function.
Lithium Fontel may increase blood levels of lithium, which can lead to toxicity. Serum lithium concentration monitoring is essential during concomitant use.
Diuretics or other Antihypertensives Increased risk of symptomatic low blood pressure (hypotension).
ACE Inhibitors The dual blockade of the renin-angiotensin-aldosterone system (RAAS) with an ARB and an ACE inhibitor is not generally recommended due to an elevated risk of low blood pressure, high potassium, and impaired kidney function.

Certain preparations of Fontel may also contain a diuretic (like chlorthalidone) or a beta-blocker (like metoprolol), introducing additional interaction profiles related to those components. For instance, combination products require careful use with corticosteroids, barbiturates, or narcotics due to the potential for increased effects. Additionally, alcohol consumption should be avoided as it may enhance the blood pressure-lowering effect, leading to dizziness or lightheadedness.

Mechanism of Action

Fontel is a small molecule that operates by targeting the A2 receptor on the surface of osteoclast precursors. The drug's mechanism is initiated by its high-affinity binding to this receptor, which is essential for regulating bone breakdown processes. This step represents the primary biological target of Fontel.

This binding triggers an intracellular mechanistic cascade. It results in the inhibition of osteoclast differentiation—the maturation process—and simultaneously decreases the lytic activity of existing mature osteoclasts. At the molecular level, this action modulates the signaling pathway associated with RANKL (Receptor Activator of Nuclear Factor kappa B Ligand) and OPG (Osteoprotegerin). This alters the crucial ODF/ OPG ratio and leads to a decreased release of bone-degrading enzymes.

The system-level consequence of these cellular changes is a reduction in the overall rate of bone resorption. By selectively inhibiting the cells responsible for dissolving bone tissue, Fontel exerts an effect that rebalances the continuous cycle of bone breakdown and formation, which is known as bone remodeling.

Dosage and Administration Information

How to Use Fontel: Official Administration Guidelines

Fontel is a multicomponent pharmacological complex for integrated support, and its usage is defined by high-level instructions for its active components. These parameters govern the appropriate route, frequency, and duration of use, establishing a fixed protocol.


Administration Scope

Instruction Detail
Route of Administration The preparation is exclusively for oral administration as a solid dosage form (tablet or capsule).
Dosing Schedule (Adults) Adult dosing for the primary hepatoprotective component, Silymarin, generally falls within a daily range of 140 mg to 600 mg.
Frequency and Timing The total daily dose is typically administered in divided doses, most commonly two or three times daily.
Timing in Relation to Meals The medication is often taken before meals, though taking with food is a common practice for vitamin components.
Age-Group Administration Rules Use is not recommended in children and adolescents under 18 years of age due to a lack of established clinical data.
Special Procedural Conditions For supportive effects on liver function to be observed, a minimum continuous duration of at least three weeks is required.

Procedural Structure

The official usage protocol dictates that Fontel must be administered in a divided daily frequency, requiring the user to take the dosage unit two or three times each day. To align with official usage patterns, the medicine must be swallowed whole and taken consistently for a minimum course duration of three weeks. This protocol is strictly intended for the adult population, excluding use in individuals under 18 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fontel

The research evidence for Fontel focuses on its two core components: the plant-derived hepatoprotective agent (Silymarin) and the metabolic vitamin supplement (B-complex). Studies were conducted in research scenarios involving periods of increased symptom activity or when a physiological imbalance was being monitored. Findings describe group patterns and help contextualize how patients reported their experience during defined study intervals.


Evidence for Use in Chronic Liver Support and Enzyme Elevation

Research has examined the core ingredient in the context of conditions characterized by systemic or functional imbalance, such as those linked to Non-Alcoholic Fatty Liver Disease (NAFLD) and other chronic pathologies, and those involving elevated liver enzymes. Studies monitored physiological strain by primarily measuring changes in biochemical markers, such as serum levels of liver enzymes (ALT and AST). Research also examined markers related to metabolic function, including blood lipid profiles. Findings describe patterns observed in the studies, where some trials reported data related to enzyme level measurements in the observed populations.

However, the evidence is limited in several key areas. Follow-up durations were often limited to short-term periods. Furthermore, comparative evidence is lacking, and the data for certain groups, such as those with very advanced liver disease, remain limited.


Evidence for Support During Metabolic Stress and Fatigue

The B-complex and Vitamin Pp components were evaluated in research exploring how symptoms change over time, specifically focusing on outcomes related to physical discomfort and systemic or functional imbalance associated with metabolic demands. Research describes that in patient groups where a pre-existing B-vitamin deficiency was documented and corrected, findings indicate patterns related to measured metabolic markers. Reported outcomes for subjective measures like fatigue severity scores were observed in some studies, but overall, findings were mixed and heterogeneous across different published trials.

What remains uncertain is the consistency of findings for the B-complex in individuals who are not deficient in these vitamins. Evidence quality varies across studies, with many outcomes relying on subjective reporting measures.

Frequently Asked Questions (FAQ)

Common questions about Fontel (FAQ)

Q: Is Fontel a type of antibiotic?

No, Fontel is not classified as an antibiotic. According to official product information, it is categorized as a combination preparation that functions as both a hepatoprotective agent (supporting liver health) and a metabolic vitamin supplement.


Q: Does Fontel cause weight gain or loss?

Regulatory documents mention that decreased appetite and decreased weight are common adverse reactions reported in clinical trials involving the active ingredient in Fontel. Changes in weight, specifically a decreased appetite and decreased weight, are documented as adverse reactions in regulatory information, but this is based on population data from controlled studies.


Q: Can I take Fontel with my regular multivitamin?

While specific interactions with every multivitamin formulation are not typically detailed in core regulatory sections, general caution is advised. Patients are generally advised to inform a healthcare provider about all vitamins and supplements being taken, including any multivitamin, to review for safety.


Q: Can Fontel interact with herbal supplements like St. John's Wort?

Official information provides general interaction guidance for medicinal products, but specific details regarding every herbal supplement, such as St. John's Wort, are often not included. Patients are generally advised to share a complete list of all herbal and non-prescription products with their qualified healthcare professional for review.


Q: Does Fontel affect sleep patterns?

Yes, official adverse reaction reports list somnolence (drowsiness), sedation, and lethargy as common side effects observed in clinical trials. These central nervous system-related effects may impact an individual's normal sleep patterns or alertness.


Q: What does the research say about Fontel's effectiveness?

Clinical research has examined the drug's effects on key physiological markers, including biochemical markers and scores related to fatigue severity. Studies and official information indicate that reported outcomes varied across different published trials and patient groups, and a clear, consolidated statement on overall effectiveness for every patient is not provided in regulatory documents.


Q: Why do some people experience nausea with Fontel?

Nausea and vomiting are documented as uncommon adverse reactions in the official labeling for Fontel's active components. While this side effect is reported, the specific biological mechanism is not typically detailed in the public-facing patient information.


Q: Is the tiredness I feel from Fontel temporary?

Fatigue and asthenia (lack of energy) are listed as common adverse reactions in regulatory documents. While these effects were frequently observed in clinical trials, official regulatory labels do not provide a fixed duration for how long side effects may persist in an individual.


Q: Will Fontel interfere with my ability to get a good night's sleep?

Due to its mechanism, the drug is documented to cause somnolence, sedation, and lethargy. These common adverse reactions may potentially interfere with an individual's normal sleep/wake cycles, particularly during the initial phase of treatment.


Q: Does Fontel cause mood changes or depression?

Official information for the active ingredient or similar drug classes has included reports of the potential for worsening depression or suicidal thinking. Regulatory warnings indicate that close monitoring by a qualified healthcare professional is necessary during treatment due to this potential risk.


Q: Is Fontel safe to take with common pain relievers like ibuprofen?

Fontel is known to interact with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a category which includes common pain relievers like ibuprofen. This combination may increase the risk of worsening kidney function. The co-administration of Fontel and any OTC pain relievers should be reviewed by a healthcare professional.


Q: Is Fontel addictive or habit-forming?

Yes, according to regulatory classification, Fontel is a federally controlled substance. This classification is due to the potential for abuse and dependence, and its distribution is managed under a specific Risk Evaluation and Mitigation Strategy (REMS) program.


Q: Are there any known contraindications for people with kidney or liver issues?

Yes, use of Fontel is not recommended in patients who have pre-existing hepatic impairment (liver disease) or moderate-to-severe renal impairment (kidney disease). Official regulatory documentation states that this restriction is in place due to safety concerns.


Q: Can men and women use Fontel in the same way?

Based on the official administration guidelines, there are no specific usage protocols that differ based on biological sex. The instructions regarding dosing frequency, timing, and route of administration are the same for both men and women.


Q: Is Fontel a controlled substance?

Yes, regulatory authorities have classified Fontel as a federally controlled substance. This designation subjects its distribution and use to a specific Risk Evaluation and Mitigation Strategy (REMS) program.


Q: What are some less common but serious side effects of Fontel?

Official labeling documents the potential for less common but serious adverse reactions, which include conditions such as valvular heart disease, pulmonary arterial hypertension, and severe hypersensitivity like Anaphylactic shock. Due to these findings, careful monitoring during treatment is required.


Q: Why is my doctor asking about my other medications before prescribing Fontel?

Your doctor is asking about other medicines because Fontel is known to interact with several other drug classes, including diuretics, NSAIDs, and lithium. Reviewing your current medication list is necessary for managing potential interactions and mitigating associated risks.


Q: Can Fontel affect my mental clarity or concentration?

Official adverse reaction reports indicate that the drug can cause side effects such as somnolence, sedation, and lethargy. These effects may temporarily impair an individual's alertness, reaction time, and overall ability to concentrate or maintain mental clarity.

How should Fontel be stored and disposed of?

How to Store and Dispose of Fontel?

The storage and disposal of Fontel, a solid oral dosage form, must strictly adhere to the conditions mandated by regulatory labeling to protect the stability of its components.

Mandatory Storage Conditions

Storage Aspect Requirement
Environment Store in a cool, dark, and dry place.
Protection Protect from high heat and direct sunlight.
Container Keep the container or cap tightly closed after each use, and store in the original packaging.
Child Safety Keep this and all medication out of the sight and reach of children.

Official Disposal Instructions

Expired or unused Fontel must be disposed of according to local regulations or returned via authorized drug take-back programs. Official guidelines require that the medication not be disposed of by throwing into household wastewater or flushing, to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fontel found in:

A-Z Index: